Article
Rheumatology
Christina Adamichou, Irini Genitsaridi, Dionysis Nikolopoulos, Myrto Nikoloudaki, Argyro Repa, Alessandra Bortoluzzi, Antonis Fanouriakis, Prodromos Sidiropoulos, Dimitrios T. Boumpas, George K. Bertsias
Summary: A machine learning algorithm was developed to assist in the diagnosis of SLE by analyzing patient data sets, leading to improved diagnostic and treatment outcomes.
ANNALS OF THE RHEUMATIC DISEASES
(2021)
Review
Medicine, General & Internal
Ami Schattner
Summary: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with diverse and atypical presentations. Early diagnosis is crucial for better outcomes, but the nonspecific symptoms and unusual organ involvement often lead to diagnostic delays.
AMERICAN JOURNAL OF MEDICINE
(2022)
Article
Immunology
Viktoryia Laurynenka, Lili Ding, Kenneth M. Kaufman, Judith A. James, John B. Harley
Summary: The association between EBV infection and SLE is reconfirmed, and the presence of anti-EBNA1 antibodies in SLE cases is more frequent than in EBV-infected controls, supporting the hypothesis that anti-EBNA1 contributes to SLE.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Immunology
Cristina Cocco, Elias Manca, Giulia Corda, Maria Maddalena Angioni, Barbara Noli, Mattia Congia, Francesco Loy, Michela Isola, Elisabetta Chessa, Alberto Floris, Lorena Lorefice, Luca Saba, Alessandro Mathieu, Gian Luca Ferri, Alberto Cauli, Matteo Piga
Summary: Brain-reactive autoantibodies are found in patients with SLE and NPSLE, with higher frequency and titers observed in NPSLE patients. The target antigens of these autoantibodies are still undetermined, but they likely include β2GPI.
FRONTIERS IN IMMUNOLOGY
(2023)
Article
Immunology
Ch Lopez-Pedrera, A. M. Patino-Trives, T. Cerdo, R. Ortega-Castro, I. Sanchez-Pareja, A. Ibanez-Costa, L. Munoz-Barrera, M. C. Abalos-Aguilera, D. Ruiz-Vilchez, P. Segui Azpilcueta, M. Espinosa, N. Barbarroja, A. Escudero-Contreras, J. P. Castano, R. Luque, R. Ortega, M. A. Aguirre, C. Perez-Sanchez
Summary: This study characterized the splicing machinery (SM) of leukocytes from patients with primary antiphospholipid syndrome (APS), systemic lupus erythematosus (SLE), and antiphospholipid syndrome with lupus (APS + SLE), and assessed its clinical involvement. The results showed that leukocytes from APS, SLE, and APS + SLE patients displayed significant and specific alterations in SM-components (SMC), which were associated with clinical features. This study identified a specific alteration of SMC in leukocytes from APS, SLE, and APS + SLE patients, which may be responsible for the development of distinctive clinical profiles.
JOURNAL OF AUTOIMMUNITY
(2023)
Article
Rheumatology
May Yee Choi, Ann Elaine Clarke, Murray Urowitz, John Hanly, Yvan St-Pierre, Caroline Gordon, Sang-Cheol Bae, Juanita Romero-Diaz, Jorge Sanchez-Guerrero, Sasha Bernatsky, Daniel J. Wallace, David Isenberg, Anisur Rahman, Joan T. Merrill, Paul R. Fortin, Dafna D. Gladman, Ian N. Bruce, Michelle Petri, Ellen M. Ginzler, Mary Anne Dooley, Rosalind Ramsey-Goldman, Susan Manzi, Andreas Jonsen, Graciela S. Alarcon, Ronald F. van Vollenhoven, Cynthia Aranow, Meggan Mackay, Guillermo Ruiz-Irastorza, Sam Lim, Murat Inanc, Ken Kalunian, Soren Jacobsen, Christine Peschken, Diane L. Kamen, Anca Askanase, Jill P. Buyon, Karen H. Costenbader, Marvin J. Fritzler
Summary: In a longitudinal analysis of a large international incident SLE cohort, three ANA assays demonstrated high positivity rates and commutability. However, over a 5-year follow-up, there was a modest variation in ANA assay performance.
ANNALS OF THE RHEUMATIC DISEASES
(2022)
Review
Immunology
Jingwen Wu, Tianyi Pang, Ziyuan Lin, Ming Zhao, Hui Jin
Summary: The aryl hydrocarbon receptor is an environmental receptor that modulates cellular response to external changes. By studying the regulation and function of AhR, we can understand disease development and discover new therapeutic targets. Several autoimmune diseases, including systemic lupus erythematosus, have been connected to AhR.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Hematology
Carl Petrus Linge, Andreas Jern, Helena Tyden, Birgitta Gullstrand, Hong Yan, Charlotte Welinder, Robin Kahn, Andreas Jonsen, John W. Semple, Anders A. Bengtsson
Summary: This study found that platelets in patients with SLE have a decreased size and a specific protein profile, including immunoglobulins, complement proteins, and autoantigens. The presence of these proteins may contribute to the pathogenesis of SLE.
THROMBOSIS AND HAEMOSTASIS
(2022)
Article
Rheumatology
May Yee Choi, Irene Chen, Ann Elaine Clarke, Marvin J. Fritzler, Katherine A. Buhler, Murray Urowitz, John Hanly, Yvan St-Pierre, Caroline Gordon, Sang-Cheol Bae, Juanita Romero-Diaz, Jorge Sanchez-Guerrero, Sasha Bernatsky, Daniel J. Wallace, David Alan Isenberg, Anisur Rahman, Joan T. Merrill, Paul R. Fortin, Dafna D. Gladman, Ian N. Bruce, Michelle Petri, Ellen M. Ginzler, Mary Anne Dooley, Rosalind Ramsey-Goldman, Susan Manzi, Andreas Jonsen, Graciela S. Alarcon, Ronald F. van Vollenhoven, Cynthia Aranow, Meggan Mackay, Guillermo Ruiz-Irastorza, Sam Lim, Murat Inanc, Kenneth Kalunian, Soren Jacobsen, Christine Peschken, Diane L. Kamen, Anca Askanase, Jill P. Buyon, David Sontag, Karen H. Costenbader
Summary: A novel longitudinal clustering technique was used to analyze comprehensive autoantibody data from a large, well-characterised, multinational inception SLE cohort, in order to determine predictive profiles of clinical outcomes.
ANNALS OF THE RHEUMATIC DISEASES
(2023)
Review
Biochemistry & Molecular Biology
Helena Idborg, Vilija Oke
Summary: Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease characterized by activation and dysregulation of the immune system. Disturbances in immune pathways and genetic susceptibility are key factors in the development of SLE. Dysregulation of cytokines, particularly interferons, has been extensively studied as potential biomarkers and treatment targets in SLE.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Review
Rheumatology
Mary K. Crow
Summary: Research has identified type I interferon (IFN-I) and autoantibodies targeting nucleic acids and nucleic acid-binding proteins as fundamental contributors to the pathogenesis of systemic lupus erythematosus (SLE). This review summarizes recent genetic analyses of SLE patients and current studies on innate and adaptive immune function, which contribute to sustained IFN-I pathway activation, immune activation, autoantibody production, inflammatory mediator generation, and tissue damage. The goal of these studies is to understand disease mechanisms, identify therapeutic targets, and develop better treatments for patients.
ANNALS OF THE RHEUMATIC DISEASES
(2023)
Review
Biochemistry & Molecular Biology
Konstantinos Parperis, Nikolaos Velidakis, Elina Khattab, Evangelia Gkougkoudi, Nikolaos P. E. Kadoglou
Summary: Pulmonary hypertension is commonly seen in patients with systemic lupus erythematosus, presenting with non-specific symptoms and negatively affecting survival. It can result from immune system dysregulation, as well as various other conditions. Early diagnosis and identification of underlying pathogenetic mechanisms are crucial for introducing targeted therapy and preventing irreversible pulmonary vascular damage. The management of pulmonary hypertension in SLE patients is similar to that of idiopathic PAH, but specific diagnostic tools for early diagnosis seem to be unavailable yet.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Genetics & Heredity
Wen Ma, Yu-Lung Lau, Wanling Yang, Yong-Fei Wang
Summary: The study aimed to improve SLE prediction accuracy using machine-learning algorithms, and the results showed that the random forest (RF) model performed well in SLE classification.
FRONTIERS IN GENETICS
(2022)
Review
Medicine, General & Internal
Michael Mahler, Chelsea Bentow, Mary-Ann Aure, Marvin J. Fritzler, Minoru Satoh
Summary: Anti-Ki/SL antibodies are associated with systemic lupus erythematosus (SLE) and Sicca syndrome, but little is known about this autoantibody system. These antibodies target a protein in the proteasome complex and have a reported prevalence of approximately 20% in SLE patients. This review aims to summarize the history, key publications, and future directions of research on anti-Ki/SL antibodies.
JOURNAL OF CLINICAL MEDICINE
(2022)
Review
Immunology
Amirhossein Azari Jafari, Mojtaba Keikha, Seyyedmohammadsadeq Mirmoeeni, Mohammad Taghi Rahimi, Reza Jafari
Summary: The study systematically reviewed the use of live parasites or parasitic products in treating mouse models of SLE, demonstrating potential immunomodulating effects on improving immunologic cells and pathological changes.
AUTOIMMUNITY REVIEWS
(2021)
Article
Multidisciplinary Sciences
Samar M. Hammad, Jasmyn R. Hardin, Dulaney A. Wilson, Waleed O. Twal, Paul J. Nietert, James C. Oates
Article
Medicine, Research & Experimental
Edith M. Williams, Leonard Egede, Jim C. Oates, Clara L. Dismuke, Viswanathan Ramakrishnan, Trevor D. Faith, Hetlena Johnson, Jillian Rose
Article
Genetics & Heredity
DeAnna Baker Frost, Willian da Silveira, E. Starr Hazard, Ilia Atanelishvili, Robert C. Wilson, Jonathan Flume, Kayleigh L. Day, James C. Oates, Galina S. Bogatkevich, Carol Feghali-Bostwick, Gary Hardiman, Paula S. Ramos
Summary: This study found widespread hypomethylation in dermal fibroblasts from African American patients with SSc, with enrichment of genes and pathways related to interferon signaling and mesenchymal differentiation, indicating potential new targets for further research.
Article
Rheumatology
Ellen Ginzler, Luiz Sergio Guedes Barbosa, David D'Cruz, Richard Furie, Kathleen Maksimowicz-McKinnon, James Oates, Mittermayer Barreto Santiago, Amit Saxena, Saira Sheikh, Damon L. Bass, Susan W. Burriss, Jennifer A. Gilbride, James G. Groark, Michelle Miller, Amy Pierce, David A. Roth, Beulah Ji
Summary: The study aimed to assess the efficacy and safety of intravenous belimumab plus standard therapy in patients of self-identified Black race with systemic lupus erythematosus. While the primary endpoint was not achieved, numerical improvements favoring belimumab were observed, especially in patients with high disease activity or renal manifestations. The safety profile of belimumab was consistent with previous SLE trials.
ARTHRITIS & RHEUMATOLOGY
(2022)
Article
Rheumatology
Lindsay N. Helget, David J. Dillon, Bethany Wolf, Laura P. Parks, Sally E. Self, Evelyn T. Bruner, Evan E. Oates, Jim C. Oates
Summary: This study developed machine learning models using renal pathology results and clinical laboratory data to predict outcomes of lupus nephritis patients at approximately 1 year, providing a valuable tool for clinical decision-making.
LUPUS SCIENCE & MEDICINE
(2021)
Article
Rheumatology
Warren A. James, Elizabeth Ogunrinde, Zhuang Wan, Diane L. Kamen, Jim Oates, Gary S. Gilkeson, Wei Jiang
Summary: This study analyzed the blood and stool samples from patients with systemic lupus erythematosus (SLE) and healthy controls (HCs) to investigate the microbial community composition. It was found that the plasma microbiome had distinct community and greater heterogeneity compared to the gut microbiome. The decreased plasma alpha diversity in patients with SLE suggests an altered plasma microbiome, which may play a role in the immune perturbations and pathogenesis of SLE.
JOURNAL OF RHEUMATOLOGY
(2022)
Article
Urology & Nephrology
Isabelle Ayoub, Bethany J. Wolf, Linyu Geng, Huijuan Song, Aastha Khatiwada, Betty P. Tsao, Jim C. Oates, Brad H. Rovin
Summary: A machine learning approach combining traditional clinical data and novel urine biomarkers was used to develop prediction models for one-year treatment response in lupus nephritis. The models showed good predictive value, with the best performance seen in predicting eGFR response. The inclusion of both traditional clinical data and novel urine biomarkers, including cytokines, chemokines, and markers of kidney damage, was found to improve the prediction accuracy.
KIDNEY INTERNATIONAL
(2022)
Article
Biochemistry & Molecular Biology
Brian Troyer, Jessalyn Rodgers, Bethany J. Wolf, James C. Oates, Richard R. Drake, Tamara K. Nowling
Summary: The development of nephritis increases the risk of morbidity and mortality in systemic lupus erythematosus patients. Standard induction therapies are only effective for approximately 50% of SLE patients with nephritis, and there is a critical need to predict treatment response before starting therapy. Elevated urine glycosphingolipids (GSLs) may serve as a potential biomarker for predicting treatment response in lupus nephritis patients.
Article
Immunology
Wangbin Ning, Da Cheng, Philip H. Howe, Chuanxiu Bian, Diane L. Kamen, Zhenwu Luo, Xiaoyu Fu, Elizabeth Ogunrinde, Liuqing Yang, Xu Wang, Quan-Zhen Li, Jim Oates, Weiru Zhang, David White, Zhuang Wan, Gary S. Gilkeson, Wei Jiang
Summary: The interaction between the microbiome and the immune response plays a crucial role in the development of normal immunity and autoimmunity. This study found that peptidoglycan (PGN) from different bacteria can have different effects on the production of autoantibodies: PGN from Bacillus subtilis drives the production of natural nonpathogenic autoantibodies, while PGN from Staphylococcus aureus induces the production of pathogenic autoantibodies.
JOURNAL OF AUTOIMMUNITY
(2022)
Letter
Rheumatology
Cecile M. Yelnik, Xianhong Xie, Marta M. Guerra, Nathalie Costedoat-Chalumeau, Arezou Khosroshahi, Diane L. Kamen, Noa Schwartz, Patricia Katz, Margaret Minett, R. Toby Amoss, April Fu, Gaelle Guettrot-Imbert, Estibaliz Lazaro, Veronique Le Guern, Jim Oates, Maria Dall Era, Jinoos Yazdany, Anna Molto, Mimi Y. Kim, Jane E. Salmon
ANNALS OF THE RHEUMATIC DISEASES
(2023)
Article
Health Care Sciences & Services
Ashley A. White, Brittany L. Smalls, Aissatou Ba, Trevor D. Faith, Viswanathan Ramakrishnan, Hetlena Johnson, Jillian Rose, Clara L. Dismuke-Greer, Jim C. Oates, Leonard E. Egede, Edith M. Williams
Summary: The study found that travel burden can have an effect on lupus patients' anxiety and depression levels.
Article
Rheumatology
Ashley A. White, Aissatou Ba, Trevor Daniel Faith, Viswanathan Ramakrishnan, Clara L. Dismuke-Greer, Jim C. Oates, Edith Marie Williams
Summary: The study aimed to assess the benefits of the Care-coordination Approach to Learning Lupus Self-Management (CALLS) intervention compared to existing lupus care. Results suggest that the CALLS intervention may improve aspects of SLE disease self-management, but further research is needed for validation.
LUPUS SCIENCE & MEDICINE
(2021)
Review
Medicine, General & Internal
Dayvia L. Russell, Jim C. Oates, Margaret Markiewicz
Summary: Klotho, traditionally known for its anti-aging properties, is now being explored for its potential role in the pathogenesis of autoimmune diseases such as rheumatoid arthritis, calling for further research and study.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES
(2021)
Article
Rheumatology
Dayvia A. Russell, Margaret Markiewicz, Jim C. Oates
LUPUS SCIENCE & MEDICINE
(2020)
Article
Rheumatology
Joy N. Jones Buie, Dorea Pleasant Jenkins, Robin Muise-Helmericks, Jim C. Oates
LUPUS SCIENCE & MEDICINE
(2019)